- Fades hyperpigmentation by fighting against dark spots, sun spots, and melasma
HAP is seeking a 12.8% rate increase in 2024 for its small group plans, largely as a result of higher demand for preventive care, health screenings and other services
Macronutrient and micronutrient supplementation and monitoring for patients on GLP-1 agonists: lessons from metabolic and bariatric surgery
Once you are viewing the tables in the larger version, you can filter, open and collapse categories, and view more of the columns and rows in a single screen view
There were some misleading news articles last week that likely misinterpreted some reported data to say that GLP-1 drugs for obesity would be cost saving
Journal of International Advanced Otology, 17 (6), 559-565